Cited by 85Autism Spectrum Disorder ResearchAutoimmune Neurological Disorders and TreatmentsSystemic Lupus Erythematosus Research

Increased serum levels of anti-ganglioside m1 auto-antibodies in autistic children: Relation to the disease severity

Open access
Mostafa, Gehan A, AL-ayadhi, Laila Y·2011·Journal of Neuroinflammation

Abstract

BACKGROUND: Autoimmunity to the central nervous system (CNS) may play a pathogenic role in a subgroup of patients with autism. This study aimed to investigate the frequency of serum anti-ganglioside M1 auto-antibodies, as indicators of the presence of autoimmunity to CNS, in a group of autistic children. We are the first to measure the relationship between these antibodies and the degree of the severity of autism. METHODS: Serum anti-ganglioside M1 antibodies were measured, by ELISA, in 54 autistic children, aged between 4 and 12 years, in comparison to 54 healthy-matched children. Autistic severity was assessed by using the Childhood Autism Rating Scale (CARS). RESULTS: Autistic children had significantly higher serum levels of anti-ganglioside M1 antibodies than healthy children (P < 0.001). The seropositivity of anti-ganglioside M1 antibodies was found in 74% (40/54) of autistic children. Serum levels of anti-ganglioside M1 antibodies were significantly higher in autistic children with severe autism (63%) than those with mild to moderate autism (37%), P = 0.001. Moreover, serum anti-ganglioside M1 antibodies had significant positive correlations with CARS (P < 0.001). CONCLUSIONS: Serum levels of anti-ganglioside M1 antibodies were increased in many autistic children. Also, their levels had significant positive correlations with the degree of the severity of autism. Thus, autism may be, in part, one of the pediatric autoimmune neuropsychiatric disorders. Further wide-scale studies are warranted to shed light on the possible etiopathogenic role of anti-ganglioside M1 auto-antibodies in autism. The role of immunotherapy in autistic patients who have increased serum levels of anti-ganglioside M1 antibodies should also be studied.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1742-2094-8-39

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Mostafa and Al-Ayadi reported significantly higher proportion of children with ASD having anti-MAG antiautoantibodies, anti-ganglioside M1, anti-neuronal and anti-nuclear antibodies than typically developing controls.

    “Mostafa and Al-Ayadi reported significantly higher proportion of children with ASD having anti-MAG antiautoantibodies, anti-ganglioside M1, anti-neuronal and anti-nuclear antibodies than typically developing controls, that positively correlated with the severity of autism symptoms (CARS scores) [109,165,166,167].”

    From Vitamin D and Autism Spectrum Disorder: A Literature Review (2016) · cites this paper as [165]

  • These antibodies positively correlated with the severity of autism symptoms (CARS scores).

    “Mostafa and Al-Ayadi reported significantly higher proportion of children with ASD having anti-MAG antiautoantibodies, anti-ganglioside M1, anti-neuronal and anti-nuclear antibodies than typically developing controls, that positively correlated with the severity of autism symptoms (CARS scores) [109,165,166,167].”

    From Vitamin D and Autism Spectrum Disorder: A Literature Review (2016) · cites this paper as [165]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Research works printed but not linked: 1

  1. Sweeten TL Bowyer SL Posey DJ Halberstadt GM McDougle CJ Increased prevalence of familial autoimmunity in probands with pervasive developmental disorders Pediatrics 2003 112 5 e420 10.1542/peds.112.5.e420 14595086 · DOI

Cited by

Sorted by citations

Authors
Mostafa, G. A., & AL-ayadhi, L. Y.
Affiliations
  • Ain Shams University (EG)
  • King Saud University (SA)
Corresponding author
Mostafa, Gehan A
Venue
Journal of Neuroinflammation
Published
2011
Volume
8
Issue
1
Pages
39
ISSN
1742-2094 (ISSN-L)
OpenAlex
W2015306125
Cited by
85
References
38
Citations by year
2026: 1 · 2025: 3 · 2024: 2 · 2023: 5 · 2022: 9 · 2021: 4 · 2020: 3 · 2019: 4 · 2018: 4 · 2017: 6 · 2016: 6 · 2015: 9 · 2014: 7 · 2013: 11 · 2012: 8
FWCI
4.71
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Journal of Neuroinflammation (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
King Abdulaziz City for Science and Technology
Topics
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
  • Health Sciences › Medicine › Neurology › Autoimmune Neurological Disorders and Treatments
  • Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
Keywords
autism spectrum disorder, autoimmunity, autism severity, pediatric autoimmune neuropsychiatric disorders, serum autoantibodies, Childhood Autism Rating Scale, immunotherapy
MeSH terms
Autistic Disorder, Autoantibodies, Central Nervous System, Child, Child, Preschool, Female, G(M1) Ganglioside, Humans, Male, Severity of Illness Index

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review